N
Nanosphere Health Sciences Inc
CNSX:NSHS
Nanosphere Health Sciences Inc
CNSX:NSHS
Price:
0.03
CAD
Market Cap:
CA$308.4k
Relative Value
The Relative Value of one NSHS stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.03 CAD, Nanosphere Health Sciences Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NSHS Relative Value
HIDDEN
Multiples Across Competitors
NSHS Competitors Multiples
Nanosphere Health Sciences Inc Competitors
Nanosphere Health Sciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
N
|
Nanosphere Health Sciences Inc
CNSX:NSHS
|
308.3k CAD | 0 | 0.8 | -1.5 | -1.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD | 15.4 | 48.5 | 32.7 | 34.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.8B CHF | 4.6 | 30.2 | 12.7 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.3B CHF | 5.3 | 21.3 | 13.1 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 5.2 | 32.1 | 15.3 | 22.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.6 | 10 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.9 | 7 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
